Recurrent chronic thromboembolic disease despite optimal anticoagulation in setting of recent COVID-19 infection.
BMJ Case Rep
; 14(1)2021 Jan 28.
Article
in English
| MEDLINE | ID: covidwho-1054633
ABSTRACT
We present a case of a 38-year-old man with a history of chronic thromboembolic pulmonary hypertension on therapeutic anticoagulation and recent hospitalisation for COVID-19 disease who was hospitalised for recurrent acute pulmonary embolism despite therapeutic anticoagulation with warfarin (International Normalized Ratio (INR) of 3.0). Our case highlights the hypercoagulable state associated with COVID-19 disease and the absence of standardised approaches to anticoagulation treatment for this population.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pulmonary Embolism
/
Warfarin
/
COVID-19
/
Anticoagulants
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Topics:
Long Covid
Limits:
Adult
/
Humans
/
Male
Language:
English
Year:
2021
Document Type:
Article
Affiliation country:
Bcr-2020-238733
Similar
MEDLINE
...
LILACS
LIS